Riccardo Canevari
Chief Executive Officer chez RADIOPHARM THERANOSTICS LIMITED
Fortune : 168 249 $ au 31/03/2024
Profil
Riccardo Canevari is currently the Chief Executive Officer, MD & Director at Radiopharm Theranostics Ltd.
He previously worked as the Senior Vice President at Novartis Oncology, Inc. and as the Chief Commercial Officer at Advanced Accelerator Applications SA.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/09/2022 | 4 605 789 ( 1,03% ) | 168 249 $ | 31/03/2024 |
Postes actifs de Riccardo Canevari
| Sociétés | Poste | Début |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Chief Executive Officer | 13/09/2021 |
Anciens postes connus de Riccardo Canevari
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Entreprise privées | 2 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
Advanced Accelerator Applications SA
 Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France. | Health Technology |
